stockrow
Friday 6 November 2026
Export LMRI’s income statement to Excel — free account
Lumexa Imaging Holdings, Inc.
LMRI Healthcare Medical Devices
Lumexa Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 7.82% from fiscal 2024.
- Revenue
- +7.82%
- EPS
- +127.1%
- Free cash flow
- +257.5%
Quarter to June 2026, against a year earlier
13.34
0.13
+0.98%
Follow LMRI
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 936 | 949 | 1,023 | 1,791 | +4.6% | 1,067 | 1,124 | 1,184 | +5.0% | |
| Gross margin, % | — | — | — | — | — | — | — | 10.57 | 10.15 | 15.40 | 63.41 | +4.8 pt | ||||||
| EBT | — | — | — | — | — | — | — | (119) | (79) | (32) | 1,030 | (48.0%) | ||||||
| EBT margin, % | — | — | — | — | — | — | — | (12.74) | (8.35) | (3.15) | 57.48 | +9.6 pt | ||||||
| Net income | — | — | — | — | — | — | — | (122) | (94) | (47) | (50) | (37.9%) | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | 13.48 | 13.66 | 14.41 | 18.66 | +3.4% | |||||
| Earnings | — | — | — | — | — | — | — | (1.76) | (1.35) | (0.66) | (0.71) | (38.6%) | ||||||
| Cash flow | — | — | — | — | — | — | — | 0.54 | 0.59 | 0.24 | 0.57 | (33.3%) | ||||||
| Capex | — | — | — | — | — | — | — | (0.35) | (0.39) | (0.29) | (0.42) | (7.9%) | ||||||
| Free cash flow | — | — | — | — | — | — | — | 0.19 | 0.19 | (0.05) | 0.16 | n/m | ||||||
| Book value | — | — | — | — | — | — | — | 0.00 | 2.33 | 8.26 | 6.41 | n/m | ||||||
| Shares, m | — | — | — | — | — | — | — | 69 | 69 | 71 | 83 | +1.1% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | |||||
| P/S | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.71 | 0.0 | ||||||
| P/B | — | — | — | — | — | — | — | 7.97 | 7.97 | 2.24 | 2.06 | 6.1 | ||||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 1.16 | 0.0 | ||||||
| EV/FCF | — | — | — | — | — | — | — | 246.79 | 246.79 | (293.46) | 138.73 | 66.7 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | 38 | 41 | 17 | 55 | (32.5%) | |||||
| Capex | — | — | — | — | — | — | — | (24) | (27) | (21) | (40) | (6.8%) | ||||||
| Free cash flow | — | — | — | — | — | — | — | 14 | 13 | (4) | 15 | n/m | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | (1) | 48 | 78 | n/m | |||||
| Net debt | — | — | — | — | — | — | — | — | 1,191 | 807 | 806 | (32.3%) | ||||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | 162 | 586 | 615 | +262.6% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | 0.00 | (11.27) | (2.74) | (5.51) | (2.7) pt | |||||
| ROIC | — | — | — | — | — | — | — | 0.00 | 2.55 | 4.39 | 48.10 | +4.4 pt | ||||||
| ROE | — | — | — | — | — | — | — | 0.00 | 0.00 | (12.60) | 0.00 | (12.6) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | 4,335 | 5,019 | — | +15.8% | |||||
| Revenue/emp, $m | — | — | — | — | — | — | — | 0.00 | 0.22 | 0.20 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026
Lumexa Imaging Holdings, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| ENOV Enovis Corporation | $1.7B | — (loss-making) | 98.6× | +1.79% (above 0%: growing) | n/m | +20.30% (above 0%: growing) | 60.83% | 0.60% | Compare |
| LMRI Lumexa Imaging Holdings, Inc. | $1.3B | — (loss-making) | 38.0× | +7.82% (above 0%: growing) | n/m | +257.54% (above 0%: growing) | 14.72% | 8.72% | |
| TNDM Tandem Diabetes Care, Inc. | $1.3B | — (loss-making) | — (loss-making) | +13.82% (above 0%: growing) | n/m | −231.98% (below 0%: shrinking) | 56.55% | (0.84%) | Compare |
| AORT Artivion, Inc. | $1.2B | — (loss-making) | — (loss-making) | +11.32% (above 0%: growing) | n/m | −202.47% (below 0%: shrinking) | 64.03% | (6.65%) | Compare |
| ATEC Alphatec Holdings, Inc. | $1.2B | — (loss-making) | — (loss-making) | +12.55% (above 0%: growing) | n/m | −149.22% (below 0%: shrinking) | 71.55% | 1.47% | Compare |
| PRCT PROCEPT BioRobotics Corporation | $1.2B | — (loss-making) | — (loss-making) | +17.96% (above 0%: growing) | n/m | −1.57% (below 0%: shrinking) | 66.28% | (27.85%) | Compare |
| IART Integra LifeSciences Holdings Corporation | $1.1B | 83.0× | 26.0× | +2.27% (above 0%: growing) | n/m | +232.94% (above 0%: growing) | 51.04% | 4.60% | Compare |
| IRMD iRadimed Corporation | $1.1B | 44.9× | 39.6× | +14.15% (above 0%: growing) | +15.91% (above 0%: growing) | +18.58% (above 0%: growing) | 76.26% | 33.63% | Compare |
| SIBN SiBone | $1.1B | — (loss-making) | — (loss-making) | +14.49% (above 0%: growing) | n/m | +31.13% (above 0%: growing) | 79.29% | (7.81%) | Compare |
| Median of peers | $1.2B | — | 39.6× | +13.19% | — | +8.51% | 65.16% | (0.12%) |